The GOG Highlight Reel – June 2022

Activity Overview

The GOG Foundation, Inc. and GOG Partners is thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that will showcase clinical trials and other newsworthy education, from major medical meetings throughout the year.

This educational event will take place twice in a calendar year, with the June 2022 highlight reel program presented virtually on Friday, June 10, 2022 from 2:30 pm – 5:30 pm ET. The GOG Foundation, Inc. and GOG Partners will share a recap outlining major medical advancements in Gynecologic Oncology through discussion and presentation of the abstracts presented during some of the best oncology and women’s cancer meetings.

This engaging session will bring together the brightest minds and world-renown researchers. Didactic presentations, debates and expert panel discussions will have you and your colleagues on the edge of your seat, as our clinical experts share best practice and ways to improve the standard of care in gynecologic malignancies.  The GOG Leadership will also present Trials In Progress.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AstraZeneca, Clovis Oncology, Immunogen, Seagen, Novocure, Mersana, and VBL Therapeutics.

Target Audience

The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.

Learning Objectives

Upon completion of the activities in this series, learners will demonstrate:

Increased knowledge regarding:

    • The current agents and regimens used in treating advanced, persistent, or recurrent cervical, endometrial, and ovarian cancers
    • The key trial data for newer therapies in treating advanced, persistent, or recurrent cervical, endometrial, and ovarian cancers
    • The current investigational agents and regimens under evaluation for the treatment of advanced, persistent, or recurrent cervical, endometrial, and ovarian cancers

Greater competence related to:

    • Selecting therapies and treatments for women with cervical, endometrial, and ovarian cancers

Greater confidence in their ability to:

    • Counsel patients with cervical, endometrial, and ovarian cancers on new and cutting-edge therapies

Moderators


Dr. Bradley Monk

Dr. Robert Coleman

Faculty


Dr. Brian Slomovitz

Dr. Leslie Randall

Dr. David O’Malley

Dr. Kathleen Moore

Dr. Ramez Eskander 

Dr. Angeles Secord

Dr. Bhavana Pothuri

Dr. Thomas Herzog

Agenda & Presentation Materials

The GOG Highlight Reel Educational Series – June 2022

Presented on Friday, June 10, 2022, 2:30 pm – 5:30 pm ET

Enduring Educational Materials will be available on demand for six months following the live virtual presentation. 

To access the recording of this symposium, please click the button below.  Once you have completed the registration, a confirmation email will be sent to the email address you provide and will include a link to access the recording.  To view the presentation slides, you may click the View Presentation links in the agenda below.

Register To Access the Symposium Recording

Special Introduction from The GOG Foundation, Inc. President
Larry J. Copeland, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
2:30 pm – 2:40 pm
Welcome & Introduction View Presentation
Bradley Monk, MD, Director, Principal Investigator, Community Research Development, HonorHealth Research Institute, University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, Arizona, USA
Robert Coleman, MD, US Oncology Research, Houston, Texas, USA
2:40 pm – 2:55 pm
Uterine Highlights from Spring 2022 Major Medical Meetings View Presentation
Brian Slomovitz, MD, Mount Sinai Medical Center, Miami Beach, Florida, USA
2:55 pm – 3:10 pm
Uterine Panel Discussion
All Session Faculty
3:10 pm – 3:30 pm
Cervical Highlights from Spring 2022 Major Medical Meetings View Presentation
Leslie Randall, MD, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA
3:30 pm – 3:50 pm
Cervical Panel Discussion
All Session Faculty
3:50 pm – 4:00 pm
Ovarian Highlights: Frontline Sensitive from Spring 2022 Major Medical Meetings View Presentation
David O’Malley, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
4:00 pm – 4:15 pm
Ovarian Frontline Sensitive Panel Discussion
All Session Faculty
4:15 pm – 4:25 pm
Ovarian Highlights: PROC from Fall 2021 Major Medical Meetings View Presentation
Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, Oklahoma, USA
4:25 pm – 4:40 pm
Ovarian PROC Panel Discussion
All Session Faculty
4:40 pm – 5:00 pm
GOG Partners, Trials in Progress
All Session Faculty
5:00 pm – 5:30 pm
Final Word
All Session Faculty

Continuing Education

In support of improving patient care, this activity has been planned and implemented by The GOG Foundation, Inc. (GOG).

Accreditation Statement

The GOG Foundation, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

AMA PRA Category 1 Credits™

The GOG Foundation, Inc. designates this on demand activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Participation

There are no fees for participating in and receiving CME credit for this activity. Participants must: 1) read the educational objectives and faculty disclosures; 2) attend the educational activity; 3) email our educational team at info@gog.org to receive and complete the educational evaluation.

Participants who complete the educational activity and evaluation will receive a certificate of credit.

Disclosure Declaration

In accordance with the ACCME Accreditation Criteria, The GOG Foundation, Inc., as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any ineligible company *(formally known as commercial interests). All Committee/Planning/Faculty members were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. All relevant financial relationships listed for these individuals have been mitigated to ensure a bias-free presentation. Please see the faculty disclosure list for detailed information.

Faculty Disclosures

  • Bradley Monk, MD, Director, Principal Investigator, Community Research Development, HonorHealth Research Institute, University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, Arizona, USA
  • Robert Coleman, MD, US Oncology Research, Houston, Texas, USA
  • Brian Slomovitz, MD, Mount Sinai Medical Center, Miami Beach, Florida, USA
  • Leslie Randall, MD, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA
  • David O’Malley, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
  • Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, Oklahoma, USA
  • Ramez Eskander, MD, UC San Diego, San Diego, California, USA
  • Angeles Alvarez Secord, MD, MHSc, Director of Gynecologic Oncology Clinical Trials, Duke Cancer Center Institute, Durham, North Carolina, USA
  • Bhavana Pothuri, MD, NYU Langone, New York City, New York, USA
  • Thomas J. Herzog, MD, University of Cincinnati, Cincinnati, Ohio, USA

Technical Requirements

This virtual activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.